.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
QuintilesIMS
Teva
Moodys
Baxter
Fish and Richardson
Chinese Patent Office
US Army
US Department of Justice

Generated: December 14, 2017

DrugPatentWatch Database Preview

RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

When do Reserpine, Hydralazine Hydrochloride And Hydrochlorothiazide patents expire, and what generic alternatives are available?

Reserpine, Hydralazine Hydrochloride And Hydrochlorothiazide is a drug marketed by Solvay, Sun Pharm Industries, and Watson Labs. and is included in four NDAs.

The generic ingredient in RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.

Summary for RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Drug patent expirations by year for RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
SolvayRESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL088376-001Oct 28, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsRESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL087556-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm IndustriesRESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL088570-001Apr 10, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsRESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL085549-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
AstraZeneca
Chubb
Harvard Business School
Cipla
UBS
Boehringer Ingelheim
Moodys
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot